Evidence map›Paper›PMID 19538924›Full record

ArticleImmunity2009

PLZF outreach: a finger in interferon's pie.

Keiko Ozato

Open access · bronzeAbstract readComment
In one paragraph

Article in Immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Host and Viral Zinc-Finger Proteins in COVID-19.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Keiko OzatoProgram on Genomics in Differentiation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. ozatok@nih.gov
National Institutes of Health · US

Funding

Gene Regulation In The Immune SystemZIAHD001310 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI OZATO, KEIKO · 2009 to 2025
$15.0M
GENE REGULATION IN THE IMMUNE SYSTEMZ01HD001310 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI OZATO, KEIKO · 1988 to 2008
$1.8M
Intramural NIH HHS Z01 HD001310
6 · The paper itself

Abstract

In this issue of Immunity, Xu et al. (2009) find that the transcription factor PLZF activates interferon-stimulated genes and facilitates natural killer cell functions. Interferon-induced PLZF phosphorylation and histone deacetylase 1 recruitment probably mediates the repressor-to-activator conversion.

Indexed as

AnimalsHistone DeacetylasesHumansImmunity, InnateInterferonsKiller Cells, NaturalKruppel-Like Transcription FactorsPromyelocytic Leukemia Zinc Finger ProteinRepressor ProteinsHistone DeacetylasesInterferonsKruppel-Like Transcription FactorsPromyelocytic Leukemia Zinc Finger ProteinRepressor ProteinsZBTB16 protein, humanZbtb16 protein, mouse

Identifiers

PMID19538924
PMCPMC4151458
OpenAlexW2055278933

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.